BioSpace News Archive

Business

Neuralstem Appoints David J. Mazzo, Ph.D., to Board of Directors

Neuralstem, Inc. announced that David J. Mazzo, Ph.D. has been appointed to the Company’s Board of Directors to be effective June 12, 2019.

May 6, 2019
·
3 min read
Deals

Aurora Cannabis to Host Third Quarter 2019 Investor Conference Call on May 15, 2019

Aurora Cannabis Inc., announced that it has scheduled its conference call to discuss the results for its third quarter ended March 31, 2019.

May 6, 2019
·
4 min read
Pharm Country

Intact Vascular Announces US Launch of the Tack Endovascular System® and First Commercial Use

Intact Vascular, Inc. announced the first commercial use of its Tack Endovascular System in multiple sites across the United States.

May 6, 2019
·
4 min read
Genetown

Blue Earth Diagnostics Announces Results from Initial Clinical Experience of 18F-rhPSMA-7 PET Imaging in High-risk Primary and Biochemical Recurrent Prostate Cancer by Technical University of Munich

Results related to Company’s investigational radiohybrid PSMA acquisition presented at AUA2019

May 6, 2019
·
9 min read
Business

TherapeuticsMD Presented New Research at the American College of Obstetricians and Gynecologists 2019 Annual Meeting that Explores How Women’s Menopausal Symptoms Affect Men

Large Survey Exclusively Focused on Women’s Male Partners Reveals a Clear Negative Impact of Menopause on Relationships, Lack of Clarity About Symptoms and Treatments, and Men’s Willingness to Discuss and Influence Decisions

May 6, 2019
·
5 min read
Deals

FSD Pharma Reports 2018 Year-End Results

FSD Pharma Inc. reported its financial and operational results for the fourth quarter and fiscal year-ended December 31, 2018.

May 6, 2019
·
6 min read
Deals

Ra Medical to Hold First Quarter 2019 Conference Call on May 13, 2019

Ra Medical Systems, Inc. announces that it will report first quarter 2019 financial results after market close on Monday, May 13, 2019.

May 6, 2019
·
1 min read
Drug Development

Can-Fite Announces Preparation for End-of-Phase II Meeting with FDA to Initiate the Phase III Liver Cancer Study for Namodenoson

Fast Track and Orphan Drug Status; No treatment currently exists for advanced liver cancer patients in whom the current standard of care does not work

May 6, 2019
·
7 min read
Job Trends

Deep Learning Chipset Shipments to Increase to 2.9 Billion Units Annually by 2025, According to Tractica

GPUs and CPUs Currently Lead in Market Share, but ASICs will Capture the Lead by 2022, with Expanded Opportunities for SoC Accelerators and FPGAs

May 6, 2019
·
3 min read
Job Trends

CaverStem Stem Cell Treatment Of Erectile Dysfunction Receives Additional International Exposure

Creative Medical Technology Holdings, Inc. announced coverage of its patented CaverStem® technology for treatment of erectile dysfunction using the patient’s own non-manipulated and non-expanded stem cells in multiple Italian publications.

May 6, 2019
·
4 min read